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Vangl is a component of the non-canonical Wnt/planar cell polarity pathway, which is implicated in
various cell polarity functions. However, little is known about its synaptic localization in neurons.
Here, we show that Vangl1 and Vangl2 are expressed in adult rat neurons, where they are tightly
associated with the postsynaptic density (PSD) fraction. Vangl2 forms a complex with PSD-95
through direct binding. Furthermore, the C-terminal PDZ-binding motif of Vangl2 is required for
localization to dendritic spines. These results suggest that Vangl2 is a new component of the PSD
that forms a complex with PSD-95 in the adult brain.
Structured summary of protein interaction:
Vangl2, Vangl1 and PSD-95 colocalize by cosedimentation (View interaction)
PSD-95 physically interacts with Vangl1 by pull down (View Interaction: 1, 2)
Vangl2 binds to PSD-95 by anti tag coimmunoprecipitation (View Interaction: 1, 2)
PSD-95 physically interacts with Vangl2 by pull down (View Interaction: 1, 2)
Vangl2 physically interacts with GluN2B, PSD-95 and Prickle2 by pull down (View interaction)
Vangl1 binds to PSD-95 by anti tag coimmunoprecipitation (View Interaction: 1, 2)
Vangl2physically interacts with Prickle2 and PSD-95 by anti bait coimmunoprecipitation (View interac-
tion)
Vangl2 physically interacts with GluN1, Prickle2, PSD-95 and GluN2B by pull down (View interaction)
PSD-95 physically interacts with GluN2B, GluN1 and Vangl2 by anti bait coimmunoprecipitation (View
interaction)
 2013 Federation of European Biochemical Societies. Published by Elsevier B.V. All rights reserved.1. Introduction
Van Gogh or Strabismus (Vang/Stbm) was originally identiﬁed
in Drosophila as a core planar cell polarity (PCP) protein, which
when mutated causes considerable misorientation of organized
epithelial structures such as wing cell hairs, leg bristles, and eye
ommatidia [1]. Vang/Stbm is evolutionarily conserved in several
species including zebraﬁsh, ﬂies, and mammals [2].
There are two Vang/Stbm family members in the mouse, Van
Gogh-like protein (Vangl) 1 and Vangl2 [3] and mRNAs of these
proteins are expressed in both the developing and adult nervous
system [4]. The semidominant mouse mutant known as looptail
(Lp) is caused by mutations in Vangl2, and heterozygous (Lp/+)
phenotypes are variable except for a characteristic bent or looped
tail, while Lp homozygotes (Lp/Lp) die mid-gestation because ofsevere neural tube defects [5]. In humans, mutations in VANGL1
and VANGL2 genes have been identiﬁed in sporadic and familial
cases of neural tube defects [6,7]. Indeed, two independent Lp
mutations in Vangl2 and mutations in VANGL1 and VANGL2 have
been shown to impair interactions with Dvl proteins, suggesting
that Vangl2-Dvl-mediated signaling underlies the cause of the neu-
ral tube defect [6–8]. Furthermore, Vangl2 was recently reported to
regulate commissural axon growth cone guidance by antagonizing
Dvl-mediated signaling [9]. Thus, accumulating evidence suggests
that Vangl2 plays critical roles in early neural development (neural
tube closure) and axon branching, but its precise synaptic localiza-
tion and biochemical properties remain elusive, particularly in the
adult brain.
Here, we show that Vangl2 is tightly associated with the post-
synaptic density (PSD) fraction of the rat brain where it forms a
protein complex with PSD-95 and N-methyl-D-aspartate (NMDA)
receptors. In addition, Vangl2 directly binds to the third PDZ do-
main of PSD-95 via its C-terminal PDZ-binding motif. Moreover,
the binding of Vangl2 to PSD-95 affected the localization of Vangl2
at the postsynaptic site.
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All experiments were carried out in accordance with the guide-
lines laid down by the animal welfare committees at the University
of Yamanashi (Yamanashi, Japan).
2.1. Antibodies
Polyclonal antibodies against mouse Vangl1 and Vangl2 were
produced by immunization of guinea pigs with a glutathione S-
transferase (GST)-Vangl1 (amino acids 14–43) and GST–Vangl2
(14–41) fusion protein, respectively, and afﬁnity-puriﬁed as re-
ported previously [10]. Other antibodies were: mouse monoclonal
anti-PSD-95 (1:500, Thermo Scientiﬁc, Waltham, MA), anti-GluN1
(1:500, BD Transduction, San Jose, CA), anti-synaptophysin
(1:1000, Millipore, Billerica, MA), anti-tubulin (1:1000, Oncogene
Research Products, La Jolla, CA), anti-Myc (1:500, Roche Applied
Science, Penzberg, Germany), rabbit polyclonal anti-Prickle2A B 
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Fig. 1. Characterization of anti-Vangl antibodies and expression of Vangl. (A) Structure
indicate transmembrane regions. Anti-Vangl antibodies were raised against a speciﬁc
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fraction; PSD, postsynaptic density fraction; sup, 1% Triton X-100-soluble fraction of PS(1:500, [11]), anti-Shank2 (1:500, a gift from Dr. M. Watanabe,
Hokkaido University, Hokkaido, Japan [12]), anti-RIM1 (1:500, a
gift from Dr. S. Kiyonaka, Kyoto University, Kyoto, Japan [13]),
anti-GFP (1:500, Life Technologies, Carlsbad, CA), guinea pig poly-
clonal anti-GluN2B, anti-GluA1 (1:500, a gift from Dr. M. Watanabe
[14]), and rat monoclonal anti-HA (1:500, Roche Applied Science).
To detect immunoﬂuorescence signals, Alexa Fluor 488- or 568-la-
beled secondary antibodies (1:500, Molecular Probes, Eugene, OR)
were used. Horseradish peroxidase-linked secondary antibodies
(1:2000–1:5000, GE Healthcare, Little Chalfont, UK) were used
for western blotting.
2.2. Cloning of mouse Vangl1 and Vangl2 cDNAs
Total RNA from the whole brain of male mice was extracted
using QIAzol reagent (Qiagen, Hilden Germany), and was subse-
quently reverse-transcribed using oligo-dT (T12–18) and M-MLV re-
verse transcriptase (Life Technologies). Full-length Vangls werengl2
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Jolla, CA).
2.3. Constructs
Expression vectors for Vangl were constructed in pCAII-EGFP,
pCAII-HA, pGEX, and pMAL-CII-MBP vectors using standard molec-
ular biological methods. The full-length rat PSD-95 cDNA was
kindly provided by Dr. S. Okabe (University of Tokyo, Tokyo, Japan).
Expression vectors for PSD-95 were constructed in pCIneo-Myc
and pGEX vectors.
2.4. Immunoprecipitation
The subcellular synaptic membrane (SM3) and PSD fractions
were prepared from rat brain as previously described [15,16]. Pro-
teins were extracted from the SM3 fraction (500 lg of protein)
with 1% deoxycholate [15,16]. The extracted proteins were then
incubated with 2 lg of antibodies for 2 h at 4 C and subsequently
incubated with 20 ll of Protein G Sepharose beads (GE Healthcare)
for 1 h at 4 C. After extensive washing of protein bound to beads
with lysis buffer (20 mM Tris–Cl, pH 7.5, 150 mM NaCl, 0.5 mM
EDTA, 1 mM DTT, 1% [w/v] Triton X-100, 10 lg/ml leupeptin, and
10 lM APMSF), the proteins were eluted by boiling the beads in
60 ll of SDS sample buffer for 5 min. Co-immunoprecipitations
using human embryonic kidney (HEK) 293 cell lysates were per-
formed as follows: expression plasmids were transfected into
HEK 293 cells using LipofectAMINE 2000 (Life Technologies). Pro-
teins expressed independently were extracted with lysis buffer,
and centrifuged at 100,000g for 30 min at 4 C to collect the
supernatant. Proteins were then mixed, incubated for 2 h at 4 C
and immunoprecipitated with anti-GFP or anti-Myc antibodies as
described above.
2.5. Pull-down assay
The lysate of HEK 293 cells expressing EGFP-Vangl was incu-
bated with 20 ll of glutathione–Sepharose beads (GE Healthcare)
containing GST–PSD-95 fusion proteins for 1 h at 4 C. After the
beads were extensively washed with lysis buffer, the bound pro-
teins were eluted and analyzed by western blotting. For the analy-A 
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Fig. 2. Immunoprecipitation of Vangl with synaptic proteins. (A–C) Immunoprecipitatio
anti-Vangl2 (A), anti-Vangl1 (B), and anti-PSD-95 (C) antibodies. The input contains 8%
antibodies used for immunoprecipitation.sis of complex formation with postsynaptic proteins, proteins
extracted from the SM3 fraction were incubated with 20 ll of
Amylose Resin (GE Healthcare) containing maltose-binding protein
(MBP)–Vangl2 fusion proteins, or with glutathione–Sepharose
beads containing GST–Vangl2 fusion proteins for 1 h at 4 C, and
pulled down as described above. GST and MBP fusion proteins
were removed from the beads by boiling them in SDS sample buf-
fer then the amount of proteins was evaluated using Coomassie
brilliant blue staining.
2.6. Primary neuron culture and immunoﬂuorescence image
acquisition
Cultured hippocampal neurons were prepared as described pre-
viously [17,18]. Cells were ﬁxed with 4% paraformaldehyde in
phosphate-buffered saline (pH 7.4) for 20 min at room tempera-
ture. Non-speciﬁc binding was blocked with 1% Block Ace (Dainip-
pon Sumitomo Pharmaceutical, Osaka, Japan) and 2% normal goat
serum containing 0.2% Triton X-100 for 1 h. The cells were then
incubated with primary antibodies for 1 h, followed by secondary
antibodies for 1 h. Fluorescence images were acquired by confocal
laser microscopy (Fluoview FV1000, Olympus, Tokyo, Japan) using
a 60 oil immersion objective lens. The ﬂuorescence intensity was
manually traced on individual dendrites and dendritic spines, and
maximum intensity and dendritic spine width were measured
using ImageJ software (NIH).
2.7. Statistical analysis
Data are expressed as means ± S.E.M. and were analyzed with
the Student’s t-test. A P value of less than 0.05 was considered sta-
tistically signiﬁcant.
3. Results
3.1. Biochemical characterization and expression of Vangl protein in
the brain
To characterize the molecular function of Vangl in the nervous
system, we ﬁrst cloned the cDNA encoding full-length mouse
Vangl1 and Vangl2 (Fig. 1A). Previous hydropathy analysisPSD-95
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of the extracts used for the assay. Asterisks indicate the IgG heavy chain from the
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served PDZ-binding motif, TSV, at the C-terminal [2]. The antigens
were designed from the N-terminal region of Vangl1 and Vangl2 to
produce anti-Vangl1 and -Vangl2 antibodies, respectively, and the
speciﬁcity of these antibodies was conﬁrmed (Fig. 1B). Western
blotting showed the speciﬁc bands of the predicted molecular
weight (59.8 kDa for Vangl2 and 60.1 kDa for Vangl1), and the
anti-Vangl2 antibody recognized only Vangl2 but not its close fam-
ily member Vangl1 and vice versa. Under the same conditions,
these antibodies recognized endogenous Vangl1 and Vangl2 in
the PSD fraction of rat brain, whereas the anti-HA antibody recog-
nized both HA–Vangl1 and HA–Vangl2 (Fig. 1B).
We next investigated the developmental changes in Vangl
expression in the mouse brain. Vangl was detected before and
immediately after birth, decreasing slightly during late postnatal
development (after P14) (Fig. 1C). Another PCP protein, Prickle2
which binds Vangl2 [19], was stably expressed during develop-
ment, whereas PSD-95 expression gradually increased with synap-
tic maturation a week after birth (Fig. 1C). These expression
patterns were consistent with those of cultured hippocampal50
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Fig. 3. The C-terminal PDZ-binding motif of Vangl is required for interaction with PSD-95
proteins. (B) Pull-down assay for the Vangl-binding domain of PSD-95. (C) In vitro associa
the interaction between Vangl and PSD-95. The input contains 8% of the extracts used f
amounts of GST-fusion proteins were loaded in B and D.neurons (Fig. 1D). We next analyzed the subcellular localization
of Vangl in the rat brain (Fig. 1E). Western blotting analysis of
biochemically prepared subcellular fractions of rat brain revealed
that Vangl was concentrated in the PSD fraction, similar to the
PSD marker protein PSD-95 (Fig. 1E). Furthermore, neither Vangl
nor PSD-95 was detected in the CSV fraction where the synaptic
vesicle protein synaptophysin was highly concentrated (Fig. 1E).
These results showed that expression of the Vangl protein in the
adult brain was tightly associated with the biochemically isolated
PSD fraction, suggesting a functional role for Vangl at the synapses.
3.2. Complex formation of Vangl2 and PSD proteins
Since Vangl is concentrated in the PSD fraction (Fig. 1E), we
examined its binding to various synaptic proteins, focusing mainly
on PSD components such as postsynaptic scaffold proteins Shank2,
PSD-95, and the glutamate receptors GluN1, GluN2B, and GluA1
(Fig. 2). First, we performed immunoprecipitation from extracts
of the synaptic membrane (SM3) fraction using the anti-Vangl2
antibody [16,20]. Among the proteins, PSD-95 and Prickle2C 
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synaptophysin, and the active zone protein RIM1 did not (Fig. 2A).
The anti-Vangl1 antibody could not co-immunoprecipitate any
PSD or active zone proteins, with the exception of a weak band for
PSD-95 (Fig. 2B). Moreover, using an anti-PSD-95 antibody, Vangl2
aswell asGluN1andGluN2Bwere co-immunoprecipitated,whereas
Vangl1, GluA1, and synaptophysin were not. These results suggest
that Vangl2 is associated with PSD-95 in the brain.
Vangl2 has three conserved amino acids (TSV) at its C-terminal
(Fig. 1A) to promote an interaction with PDZ domain-containing
proteins [21]. Considering our immunoprecipitation results, we
speculated that Vangl2 binds directly to some PDZ domains of
PSD-95. To test our hypothesis, we made various GST-fusion pro-
teins containing different domains of PSD-95 (Fig. 3A). The pull-
down assay with EGFP–Vangl2 revealed that Vangl2 speciﬁcally
bound to the third PDZ (PDZ3) domain of PSD-95 (Fig. 3B).
To conﬁrm the speciﬁcity of the interaction between Vangl2
and PSD-95, EGFP–Vangl2 or Myc-PSD-95 was examined by an
immunoprecipitation assay (Fig. 3C). Myc-PSD-95 co-immunopre-
cipitated with EGFP–Vangl2, but not with EGFP–Vangl2–DTSV,
which lacks the C-terminal TSV motif. Likewise, EGFP–Vangl2,
but not EGFP–Vangl2–DTSV, co-immunoprecipitated with Myc-
PSD-95, suggesting an essential role for the C-terminal Vangl2
TSV motif in PSD-95 binding. This binding was also conﬁrmed by
pull-down assays using GST–PSD-95–PDZ3 and EGFP–Vangl2 or
EGFP–Vangl2–DTSV (Fig. 3D). Interestingly, we found that EGFP–
Vangl1 bound to the PDZ3 domain of PSD-95 via its C-terminal
TSV motif (Fig. 3B–D), although the anti-Vangl1 antibody was un-
able to detect PSD proteins (Fig. 2B). We speculate that there arePSD-95
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To elucidate further details about the Vangl2/PSD-95 complex,
the rat brain SM3 fraction was incubated with various MBP-tagged
regions of Vangl2 (Fig. 4A). Consistent with the previous ﬁnding of
a direct interaction, PSD-95 could only bind to the C-terminal
region of Vangl2, and not to the N-terminal or C-terminal-DTSV
region (Fig. 4B). Intriguingly, GluN2B was detected from the pull-
down assay using the Vangl2 C-terminal region (Vangl2-C,
Fig. 4B), indicating a direct interaction between Vangl2 and PSD-
95 forming a PSD-95/NMDA receptor complex at the PSD. By
contrast, Prickle2 could bind to both the C-terminal and
C-terminal-DTSV regions (Fig. 4B). This result is consistent with
two independent previous studies showing the direct interaction
of Prickle2 with the C-terminal region of Vangl2 [19], and an inter-
action of Prickle2 with PSD-95 [11]. Although loop tail mutations
are known to affect the Vangl2 interaction with other proteins such
as Dvl proteins [8], the binding site of Vangl2 to PSD-95 was lo-
cated between amino acids 480 and 521, which excludes the loop
tail mutation site (Fig. 4A and C).
3.3. Role of the Vangl2/PSD-95 complex in the localization of Vangl2 at
dendritic spines
We next examined whether the C-terminal TSV motif of Vangl2
affects its localization at synapses (Fig. 5). When HA–Vangl2 was37
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Fig. 5. The C-terminal PDZ-binding motif of Vangl2 is required for its synapse-
speciﬁc localization. (A) Synaptic distribution of exogenously overexpressed
Vangl2. Cultured hippocampal neurons transfected with HA–Vangl2 or HA–
Vangl2–DTSV at four days in vitro were immunolabeled with anti-HA (green) and
anti-Bassoon (red) as a synaptic marker. A few Vangl2 aggregations on dendrites
did not colocalize with the labeling of Bassoon (arrowheads). (B) Variation of
ﬂuorescence intensities (white lines in A) for HA (green) and Bassoon (red)
normalized to each maximum ﬂuorescence intensity. (C) Quantitative analysis of
Vangl2 distribution at dendritic spines. By collecting identiﬁable dendritic spines
colocalized with Bassoon, the sizes of dendritic spines measured with HA labeling
did not differ signiﬁcantly (left). The ratio of maximum ﬂuorescence intensity at
dendrites and dendritic spines was signiﬁcantly higher in HA–Vangl2 (n = 39) than
in HA–Vangl2–DTSV (n = 40) (right). Data are means ± S.E.M. ⁄⁄⁄P < 0.001, Student’s
t-test.
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served in spine-like structures, and were partly colocalized with
endogenous Bassoon used as a synaptic marker (Fig. 5A and B,
upper panel). However, HA–Vangl2–DTSV was relatively uniformly
distributed in dendrites and dendritic spines (Fig. 5A and B, lower
panel). Indeed, statistical analysis based on the immunoﬂuores-
cence intensity of HA showed that HA–Vangl2 was more concen-
trated at dendritic spines than HA–Vangl2–DTSV (Fig. 5C).
4. Discussion
The biochemical analyses of the present study indicate that the
core PCP protein Vangl2 is a novel component of the PSD and sug-
gest a potential role for Vangl2 in the function of synaptic forma-
tion, transmission, and/or modulation.
Consistently, exogenously overexpressed Vangl2 colocalized
with other synaptic proteins in cultured hippocampal neurons.We therefore propose that Vangl2 plays a role in PSD-95-mediated
synaptic functions as a PSD protein. However, in previous proteo-
mics analysis of immunoprecipitated protein complexes with
PSD-95 and the NMDA receptor, Vangl2 has not been detected
[22,23]. Although proteomic characterization using immunopre-
cipitation is sufﬁciently powerful to systematically analyze and
propose a model of cell signaling with the complex protein net-
work, its availability to probe particular proteins is limited. In fact,
another PCP protein, Prickle2, was not detected by proteomics
analysis [22,23], even though it was demonstrated to bind PSD-
95 and was shown to localize at the PSD using immunoelectron
microscopy [11]. The technical conditions necessary for solubiliz-
ing PSD proteins use the harsh detergent deoxycholate heret this
may occasionally cause disruption of native protein conformations.
Therefore, at present, we cannot be sure that a tripartite complex
of Vangl2–PSD-95–NMDA receptors exists in the intact brain. Fur-
ther reﬁned biochemical and cell biological analyses will therefore
be needed to clarify this.
Interestingly, some transmembrane proteins such as neuroli-
gins and the beta 1-adrenergic receptor have been shown to bind
to the third PDZ domain of PSD-95 [24,25]. Because the C-terminal
TSV motif of Vangl2 is a typical consensus motif for PDZ domain
binding [21] and similar to that of neuroligins, they might compete
with each other for binding to PSD-95 in vivo. Neuroligin1 is known
to promote synapse maturation through its interaction with beta-
neurexins [26], and some family members such as neuroligin3 and
neuroligin4 appear to be involved in autism spectrum disorders
[27]. Thus, it would be of interest to clarify whether and how
Vangl2 affects the localization and function of neuroligins in vivo.
Further studies to address this question will shed new light on
the physiological function of Vangl2 in higher brain function and
related disorders.
The means by which Vangl2 is correctly and speciﬁcally local-
ized to the plasma membrane in different cell types is largely un-
clear. For example, in Drosophila, plasma membrane formation
during early embryogenesis is dependent on the complex formed
between Vang/Stbm and the tumor suppressor and adaptor protein
Discs-Large (Dlg) through its C-terminal PDZ-binding motif. Vang/
Stbm localized at a speciﬁc membrane compartment efﬁciently re-
cruits Dlg; however, a mutated Vang/Stbm in which the C-terminal
PDZ binding motif is changed to abolish the interaction results in
disrupted recruitment. Nevertheless, both wild-type and mutant
Vang/Stbm show similar distribution to the membrane compart-
ment, suggesting that the motif is not required for the speciﬁc
localization of Vang/Stbm [28]. In addition, Scribble, another PCP
protein required for the establishment of epithelial polarity, has
been shown to interact with Lgl2 and Vangl2, where Vangl2 binds
to speciﬁc PDZ domains of Scribble. In Madin-Darby canine kidney
cells, exogenously expressed full-length Vangl2 and PDZ-binding
motif-lacking Vangl2 show similar localization patterns [29].
Therefore, we show here for the ﬁrst time that the C-terminal
PDZ-binding motif of Vangl2 is required for its localization. We
speculate that Vangl2 could be recruited to the PSD by its binding
partner PSD-95 as HA–Vangl2–DTSV showed a relatively diffuse
pattern in dendrites and dendritic spines of cultured neurons com-
pared with HA–Vangl2 (Fig. 5).
Vangl2, by contrast, was required in a previous study for Wnt-
stimulated outgrowth and guidance of commissural axons [9].
Our biochemical analysis of subcellular localization may support
a presynaptic distribution of Vangl2, because presynaptic active
zone proteins such as CAST and Bassoon have also been detected
in the PSD fraction [16,30]. This is similar to the Scribble1 localiza-
tion at both pre- and post-synapses [31], where mislocalization of
signaling pathways downstream of Scribble1 at the postsynapse
causes defects in actin dynamics and dendritic spine morphologies
[32]. In conclusion, we propose that PCP proteins located at the
T. Yoshioka et al. / FEBS Letters 587 (2013) 1453–1459 1459PSD such as Vangl2, Prickle2, and Scribble1 may regulate the struc-
tural and molecular organization at the synapse.
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